Literature DB >> 10874524

Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.

D J van Kraaij1, R W Jansen, F W Gribnau, W H Hoefnagels.   

Abstract

Long term prescription of diuretics for heart failure is very prevalent among elderly patients, although the rationale for such a treatment strategy is often unclear, as diuretics are not indicated if volume overload is absent. The concept of diastolic heart failure in the elderly might particularly change the role of diuretic therapy, since diuretics may have additional adverse effects in these patients. This paper reviews the effects of diuretic therapy in elderly patients with heart failure, emphasising the differences between patients with normal and decreased left ventricular systolic function. Studies on diuretic withdrawal in elderly patients with heart failure are discussed, with emphasis on issues involved in decision making such as diuretic dose reduction and withdrawal in elderly patients and factors that have been established to predict successful withdrawal. Existing guidelines on the prescription of diuretics in elderly patients with heart failure with normal and decreased left ventricular systolic function and in those with diastolic heart failure are also discussed. By reducing intravascular volume, diuretics may further impair ventricular diastolic filling in patients with diastolic heart failure and thus reduce stroke volume. Indeed, preliminary studies demonstrate that diuretics may provoke or aggravate hypotension on standing and after meals in these patients. Therefore, it is suggested that elderly patients with heart failure with intact left ventricular systolic function should not receive long term diuretic therapy, unless proven necessary to treat or prevent congestive heart failure. This implies that physicians should carefully evaluate the opportunities for diuretic dose tapering or withdrawal in all of these patients, and that a cautiously guided intermittent diuretic treatment modality may be critical in the care for older patients with heart failure with intact left ventricular systolic function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10874524     DOI: 10.2165/00002512-200016040-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  113 in total

1.  Monitoring hypovolemia in healthy elderly subjects by measuring blood pressure response to Valsalva's maneuver.

Authors:  D J van Kraaij; R W Jansen; W H Hoefnagels
Journal:  Geriatr Nephrol Urol       Date:  1999

Review 2.  Successes and failures of current treatment of heart failure.

Authors:  J G Cleland; K Swedberg; P A Poole-Wilson
Journal:  Lancet       Date:  1998-08       Impact factor: 79.321

Review 3.  The management of chronic heart failure.

Authors:  J N Cohn
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

4.  Diastolic dysfunction in elderly patients with congestive heart failure.

Authors:  W F Wong; S Gold; O Fukuyama; P L Blanchette
Journal:  Am J Cardiol       Date:  1989-06-15       Impact factor: 2.778

5.  The effect of age and sodium depletion on cardiovascular response to orthostasis.

Authors:  R P Shannon; J Y Wei; R M Rosa; F H Epstein; J W Rowe
Journal:  Hypertension       Date:  1986-05       Impact factor: 10.190

6.  Plasma arginine vasopressin in dehydrated elderly patients.

Authors:  J Kirland; M Lye; C Goddard; E Vargas; I Davies
Journal:  Clin Endocrinol (Oxf)       Date:  1984-04       Impact factor: 3.478

Review 7.  Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective.

Authors:  R S Vasan; E J Benjamin; D Levy
Journal:  J Am Coll Cardiol       Date:  1995-12       Impact factor: 24.094

8.  Diuretic withdrawal--a need for caution.

Authors:  A J Taggart; D G McDevitt
Journal:  Curr Med Res Opin       Date:  1983       Impact factor: 2.580

9.  Withdrawal of antihypertensive drug treatment: time-course for redevelopment of hypertension and effects upon left ventricular mass.

Authors:  B Fagerberg; J Wikstrand; G Berglund; M Hartford; S Ljungman; I Wendelhag
Journal:  J Hypertens       Date:  1992-06       Impact factor: 4.844

10.  Use of cardiovascular drugs in an older Swedish population.

Authors:  P Wills; J Fastbom; C B Claesson; C Cornelius; M Thorslund; B Winblad
Journal:  J Am Geriatr Soc       Date:  1996-01       Impact factor: 5.562

View more
  4 in total

1.  Torasemide: a pharmacoeconomic review of its use in chronic heart failure.

Authors:  M Young; G L Plosker
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Determining the incidence of drug-associated acute kidney injury in nursing home residents.

Authors:  Steven M Handler; Pui Wen Cheung; Colleen M Culley; Subashan Perera; Sandra L Kane-Gill; John A Kellum; Zachary A Marcum
Journal:  J Am Med Dir Assoc       Date:  2014-05-10       Impact factor: 4.669

Review 3.  Acute kidney injury in the elderly.

Authors:  Khaled Abdel-Kader; Paul M Palevsky
Journal:  Clin Geriatr Med       Date:  2009-08       Impact factor: 3.076

Review 4.  Management of acute renal failure in the elderly patient: a clinician's guide.

Authors:  Ching M Cheung; Arvind Ponnusamy; John G Anderton
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.